{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:39:45Z","timestamp":1792172385879,"version":"4.4.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009697","name":"North American Membrane Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.compbiomed.2022.105668","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T02:03:11Z","timestamp":1653616991000},"page":"105668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8187-2120","authenticated-orcid":false,"given":"Pukar","family":"Khanal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal S.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwambhar V.","family":"Bhandare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prarambh S.R.","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Shastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5916-901X","authenticated-orcid":false,"given":"B.M.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5564-2121","authenticated-orcid":false,"given":"Shailendra S.","family":"Gurav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darasaguppe R.","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subarna","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2022.105668_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","article-title":"Coronaviruses: an overview of their replication and pathogenesis","volume":"1282","author":"Fehr","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/j.compbiomed.2022.105668_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3945\/an.115.010207","article-title":"Impact of obesity and metabolic syndrome on immunity","volume":"7","author":"Andersen","year":"2016","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.compbiomed.2022.105668_bib4","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1172\/JCI200421318","article-title":"The immune response to AIDS virus infection: good, bad, or both","volume":"113","author":"Deeks","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.compbiomed.2022.105668_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105980","article-title":"Chloroquine as a prophylactic agent against COVID-19","volume":"55","author":"Gendrot","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.compbiomed.2022.105668_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s42003-020-01577-x","article-title":"Identification of 3-chymotrypsin like protease (3CLPro) inhibitors as potential anti-SARS-CoV-2 agents","volume":"4","author":"Mody","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.compbiomed.2022.105668_bib7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-020-2601-5","article-title":"Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity","volume":"587","author":"Shin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2022.105668_bib8","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.compbiomed.2022.105668_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117900","article-title":"The immune system and COVID-19: friend or foe","volume":"256","author":"Yazdanpanah","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.compbiomed.2022.105668_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11101-014-9387-8","article-title":"Naturally occurring chalcones and their biological activities","volume":"15","author":"Rozmer","year":"2016","journal-title":"Phytochemistry Rev."},{"key":"10.1016\/j.compbiomed.2022.105668_bib11","first-page":"4761","article-title":"Effects of chalcone derivatives on players of the immune system","volume":"9","author":"Lee","year":"2015","journal-title":"Drug Des DevelTher"},{"key":"10.1016\/j.compbiomed.2022.105668_bib12","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1016\/j.bmcl.2018.04.042","article-title":"Antiviral properties and interaction of novel chalcone derivatives containing a purine and benzenesulfonamide moiety","volume":"28","author":"Zhou","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.compbiomed.2022.105668_bib13","doi-asserted-by":"crossref","first-page":"6011","DOI":"10.1039\/C9RA00618D","article-title":"Novel chalcone derivatives containing a 1,2,4-triazine moiety: design, synthesis, antibacterial and antiviral activities","volume":"9","author":"Tang","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2022.105668_bib14","doi-asserted-by":"crossref","first-page":"24483","DOI":"10.1039\/D0RA03684F","article-title":"New chalcone derivatives: synthesis, antiviral activity and mechanism of action","volume":"10","author":"Fu","year":"2020","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2022.105668_bib15","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1093\/bioinformatics\/btt322","article-title":"DIGEP-Pred: web service for in silico prediction of drug-induced gene expression profiles based on structural formula","volume":"29","author":"Lagunin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.compbiomed.2022.105668_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2022.105668_bib18","doi-asserted-by":"crossref","first-page":"D362","DOI":"10.1093\/nar\/gkw937","article-title":"The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible","volume":"45","author":"Szklarczyk","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.105668_bib19","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.compbiomed.2022.105668_bib20","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1021\/ci020048r","article-title":"PASS biological activity spectrum predictions in the enhanced open NCI database browser","volume":"43","author":"Poroikov","year":"2003","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.compbiomed.2022.105668_bib21","doi-asserted-by":"crossref","first-page":"10024","DOI":"10.1021\/ja00051a040","article-title":"UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations","volume":"114","author":"Rapp\u00e9","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.compbiomed.2022.105668_bib22","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1093\/nar\/gkg520","article-title":"SWISS-MODEL: an automated protein homology-modeling server","volume":"31","author":"Schwede","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.105668_bib23","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2022.105668_bib24","series-title":"Discovery S","author":"DassaultSyst\u00e8mes Biovia","year":"2019"},{"key":"10.1016\/j.compbiomed.2022.105668_bib25","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.compbiomed.2022.105668_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105223","article-title":"System biology-based investigation of Silymarin to trace hepatoprotective effect","volume":"142","author":"Dwivedi","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2022.105668_bib27","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/ci500020m","article-title":"Open source drug discovery consortium, Lynn A. g_mmpbsa--a GROMACS tool for high-throughput MM-PBSA calculations","volume":"54","author":"Kumari","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.compbiomed.2022.105668_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47249-7","article-title":"Differential binding affinity of tau repeat region R2 with neuronal-specific \u03b2-tubulin isotypes","volume":"9","author":"Bhandare","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2022.105668_bib29","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1080\/07391102.2017.1310670","article-title":"The proteinopathy of D169G and K263E mutants at the RNA Recognition Motif (RRM) domain of tar DNA-binding protein (tdp43) causing neurological disorders: a computational study","volume":"36","author":"Bhandare","year":"2018","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2022.105668_bib30","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/prot.340170408","article-title":"Essential dynamics of proteins","volume":"17","author":"Amadei","year":"1993","journal-title":"Proteins"},{"key":"10.1016\/j.compbiomed.2022.105668_bib31","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/07391102.1996.10508874","article-title":"An efficient method for sampling the essential subspace of proteins","volume":"13","author":"Amadei","year":"1996","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiomed.2022.105668_bib32","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/protein\/8.11.1129","article-title":"Essential dynamics of the cellular retinol-binding protein-evidence for ligand-induced conformational changes","volume":"8","author":"Van Aalten","year":"1995","journal-title":"Protein Eng."},{"key":"10.1016\/j.compbiomed.2022.105668_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.785964","article-title":"Integration of system biology tools to investigate huperzine A as an anti-Alzheimer agent","volume":"12","author":"Khanal","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaim.2020.11.004","article-title":"Network pharmacology of AYUSH recommended immune-boosting medicinal plants against COVID-19","volume":"13","author":"Khanal","year":"2022","journal-title":"J. Ayurveda Integr. Med."},{"key":"10.1016\/j.compbiomed.2022.105668_bib35","series-title":"The Chemistry of Chalcones and Related Compounds","first-page":"285","author":"Dhar","year":"1981"},{"key":"10.1016\/j.compbiomed.2022.105668_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib37","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiomed.2022.105668_bib38","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","article-title":"HIF transcription factors, inflammation, and immunity","volume":"41","author":"Palazon","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.compbiomed.2022.105668_bib39","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri.2016.99","article-title":"Emerging roles of p53 and other tumour-suppressor genes in immune regulation","volume":"16","author":"Mu\u00f1oz-Fontela","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib40","doi-asserted-by":"crossref","first-page":"O14","DOI":"10.1186\/ar3418","article-title":"Immunomodulatory cytokines: directing and controlling immune activation","volume":"13","author":"Simon","year":"2011","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.compbiomed.2022.105668_bib41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","article-title":"Toll-like receptor signaling pathways","volume":"5","author":"Kawasaki","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib42","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1038\/onc.2008.26","article-title":"Foxo in the immune system","volume":"27","author":"Peng","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.compbiomed.2022.105668_bib43","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cellimm.2015.01.018","article-title":"Estrogen receptors regulate innate immune cells and signaling pathways","volume":"294","author":"Kovats","year":"2015","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib44","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.3390\/cells8111380","article-title":"Wnt signaling in the regulation of immune cell and cancer therapeutics","volume":"8","author":"Haseeb","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.compbiomed.2022.105668_bib45","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1600-065X.2008.00734.x","article-title":"Function of Nod-like receptors in microbial recognition and host defense","volume":"227","author":"Franchi","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.compbiomed.2022.105668_bib47","author":"Disney"},{"key":"10.1016\/j.compbiomed.2022.105668_bib48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virol.2006.12.035","article-title":"Deubiquitination in virus infection","volume":"362","author":"Lindner","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.compbiomed.2022.105668_bib49","doi-asserted-by":"crossref","first-page":"15199","DOI":"10.1128\/JVI.79.24.15199-15208.2005","article-title":"The papain-like protease from the severe acute respiratory syndrome coronavirus is adeubiquitinating enzyme","volume":"79","author":"Lindner","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib50","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1007\/s00018-004-4242-5","article-title":"Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus","volume":"61","author":"Kuhn","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.compbiomed.2022.105668_bib51","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2022.105668_bib52","doi-asserted-by":"crossref","first-page":"D1417","DOI":"10.1093\/nar\/gkab1013","article-title":"Varidt 2.0: structural variability of drug transporter","volume":"50","author":"Fu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiomed.2022.105668_bib53","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acschemneuro.1c00694","article-title":"Molecular mechanism for the allosteric inhibition of the human serotonin transporter by antidepressant escitalopram","volume":"13","author":"Xue","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.compbiomed.2022.105668_bib54","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/acschemneuro.8b00729","article-title":"How does chirality determine the selective inhibition of histone deacetylase 6? A lesson from trichostatina enantiomers based on molecular dynamics","volume":"10","author":"Zhang","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.compbiomed.2022.105668_bib55","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/acschemneuro.8b00059","article-title":"Exploring the binding mechanism of metabotropic glutamate receptor 5 negative allosteric modulators in clinical trials by molecular dynamics simulations","volume":"9","author":"Fu","year":"2018","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.compbiomed.2022.105668_bib56","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1039\/C7CP07869B","article-title":"Computational identification of the binding mechanism of a triple reuptake inhibitor amitifadine for the treatment of major depressive disorder","volume":"20","author":"Xue","year":"2018","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.compbiomed.2022.105668_bib57","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/s41594-020-0440-6","article-title":"Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur","volume":"27","author":"Jin","year":"2020","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib58","doi-asserted-by":"crossref","first-page":"692168","DOI":"10.3389\/fchem.2021.692168","article-title":"Catalytic dyad residues His41 and Cys145 impact the catalytic activity and overall conformational fold of the main SARS-CoV-2 protease 3-chymotrypsin-like protease","volume":"9","author":"Ferreira","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.compbiomed.2022.105668_bib59","first-page":"9","article-title":"Dual targeting of 3CLpro and PLpro of SARS-CoV-2: a novel structure-based design approach to treat COVID-19","volume":"3","author":"Rajpoot","year":"2021","journal-title":"CRSB"},{"key":"10.1016\/j.compbiomed.2022.105668_bib60","doi-asserted-by":"crossref","first-page":"16584","DOI":"10.1021\/acsomega.1c01797","article-title":"Inhibition of the 3CL protease and SARS-CoV-2 replication by dalcetrapib","volume":"6","author":"Niesor","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.compbiomed.2022.105668_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20718-8","article-title":"The complex structure of GRL0617 and SARS-CoV-2 PLpro reveals a hot spot for antiviral drug discovery","volume":"12","author":"Fu","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2022.105668_bib62","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11030-021-10220-8","article-title":"Identifying structural-functional analogue of GRL0617, the only well-established inhibitor for papain-like protease (PLpro) of SARS-CoV2 from the pool of fungal metabolites using docking and molecular dynamics simulation","volume":"26","author":"Rao","year":"2022","journal-title":"Mol. Divers."},{"key":"10.1016\/j.compbiomed.2022.105668_bib63","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1021\/acsinfecdis.1c00070","article-title":"Small-molecule inhibitors of the coronavirus spike: ACE2 protein\u2013protein interaction as blockers of viral attachment and entry for SARS-CoV-2","volume":"7","author":"Bojadzic","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.compbiomed.2022.105668_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nri3131","article-title":"Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways","volume":"12","author":"Mocarski","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib65","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1478-811X-12-29","article-title":"\u03b2-catenin promotes the type I IFN synthesis and the IFN-dependent signaling response but is suppressed by influenza A virus-induced RIG-I\/NF-\u03baB signalling","volume":"12","author":"Hillesheim","year":"2014","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.compbiomed.2022.105668_bib66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1189\/jlb.71.4.565","article-title":"Interferon\u2010\u03b1 as an immunotherapeutic protein","volume":"71","author":"Brassard","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib67","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/s41419-020-2395-2","article-title":"Inhibition of topoisomerase IIA (Top2\u03b1) induces telomeric DNA damage and T cell dysfunction during chronic viral infection","volume":"11","author":"Dang","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.compbiomed.2022.105668_bib68","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1128\/JVI.00422-06","article-title":"CD80 and CD86 control antiviral CD8+ T-cell function and immune surveillance of murine gammaherpesvirus 68","volume":"80","author":"Fuse","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.compbiomed.2022.105668_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003229","article-title":"Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis","volume":"9","author":"Berri","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.compbiomed.2022.105668_bib70","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.3390\/ijms21176412","article-title":"The HMOX1 pathway as a promising target for the treatment and prevention of SARS-CoV-2 of 2019 (COVID-19)","volume":"21","author":"Batra","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2022.105668_bib71","article-title":"RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection","volume":"23","author":"Zhang","year":"2022","journal-title":"Briefings Bioinf."},{"key":"10.1016\/j.compbiomed.2022.105668_bib72","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/bib\/bbab062","article-title":"The miRNA: a small but powerful RNA for COVID-19","volume":"22","author":"Zhang","year":"2021","journal-title":"Briefings Bioinf."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482522004577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482522004577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:00:16Z","timestamp":1757880016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482522004577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":71,"alternative-id":["S0010482522004577"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105668","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Computational investigation of benzalacetophenone derivatives against SARS-CoV-2 as potential multi-target bioactive compounds","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2022.105668","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105668"}}